Benzinga | May 4, 2021 04:49PM EDT

Jazz Pharmaceuticals Q1 EPS $3.92 Beats $3.74 Estimate, Sales $607.58M Miss $611.49M Estimate

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported quarterly earnings of $3.92 per share which beat the analyst consensus estimate of $3.74 by 4.81 percent. This is a 771.11 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $607.58 million which missed the analyst consensus estimate of $611.49 million by 0.64 percent. This is a 13.62 percent increase over sales of $534.73 million the same period last year.